$46.8B Roche, Genentech Deal Ends Shareholder Suit
A consolidated shareholder derivative lawsuit is being wrapped up as part of a $46.8 billion deal that will see Roche Holding AG acquire the Genentech Inc. stock it doesn't already own...To view the full article, register now.
Already a subscriber? Click here to view full article